Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-031875
Filing Date
2025-04-15
Accepted
2025-04-15 13:13:49
Documents
16
Period of Report
2025-02-11
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0238102-8ka1_adaptin.htm   iXBRL 8-K/A 28746
2 AUDITED FINANCIAL STATEMENTS OF ADAPTIN BIO OPERATING CORPORATION (FORMERLY ADAP ea023810201ex99-1_adaptin.htm EX-99.1 213240
3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION ea023810201ex99-2_adaptin.htm EX-99.2 95156
4 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA ea023810201ex99-3_adaptin.htm EX-99.3 72473
  Complete submission text file 0001213900-25-031875.txt   659619

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cik0001938571-20250211.xsd EX-101.SCH 3080
6 XBRL LABEL FILE cik0001938571-20250211_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE cik0001938571-20250211_pre.xml EX-101.PRE 22393
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0238102-8ka1_adaptin_htm.xml XML 4629
Mailing Address 3540 TORINGDON WAY SUITE 200, #250 CHARLOTTE NC 28277
Business Address 3540 TORINGDON WAY SUITE 200, #250 CHARLOTTE NC 28277 (888) 609-1498
ADAPTIN BIO, INC. (Filer) CIK: 0001938571 (see all company filings)

EIN.: 881566415 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-56583 | Film No.: 25838600
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)